PMID- 11050292 OWN - NLM STAT- MEDLINE DCOM- 20001229 LR - 20190624 IS - 0014-2999 (Print) IS - 0014-2999 (Linking) VI - 407 IP - 1-2 DP - 2000 Oct 27 TI - GABA(B) receptor mechanism and imipramine-induced antinociception in ligated and non-ligated mice. PG - 65-72 AB - This study concerned the effects of GABA(B) receptor agents on imipramine-induced antinociception in ligated and non-ligated mice in hot-plate test. The data showed that different doses of morphine (3, 6 and 9 mg/kg) induced a dose-dependent antinociception in non-ligated or ligated mice. However, the opioid response was decreased in the ligated animals. Intracerebroventricular (i.c.v.) administration of imipramine (5, 10, 20 and 40 microg/mouse) did not induce antinociception in either non-ligated or ligated mice. However, the response induced in the ligated mice was less than that induced in the non-ligated animals. Intraperitoneal (i.p.) administration of imipramine (10, 20, 30 and 40 mg/kg) induced antinociception in both ligated and non-ligated animals. The responses to the drug were not significantly different in the two groups. Administration of baclofen either i.c.v. (0.125, 0.25 and 0. 5 microg/mouse) or i.p. (0.5, 1, 2 and 4 mg/kg) induced antinociception. The response to the drug was not significantly different in ligated and non-ligated mice. I.c.v. administration of a lower dose of baclofen (0.125 microg/mouse) with different doses of imipramine (2.5, 5 and 10 mg/kg) potentiates the response of imipramine. This effect was reduced by i.c.v. injection of GABA(B) receptor antagonist, CGP35348 [P-(3-aminopropyl)-p-diethoxymethyl-phosphinic acid] (20 microg/mouse). The higher dose of antagonist (20 microg/mouse) also decreased the response induced by baclofen or imipramine. CGP35348 itself (2.5, 5, 10 and 20 microg/mouse) induced dose-dependent antinociception with no significant difference in the ligated and non-ligated mice. It is concluded that a GABA receptor mechanism(s) may modulate the antidepressant-induced antinociception. FAU - Zarrindast, M AU - Zarrindast M AD - Department of Pharmacology, School of Medicine, Tehran University of Medical Science, P.O. Box 13145-784, Tehran, Iran. zarinmr@ams.ac.ir FAU - Valizadeh, S AU - Valizadeh S FAU - Sahebgharani, M AU - Sahebgharani M LA - eng PT - Journal Article PL - Netherlands TA - Eur J Pharmacol JT - European journal of pharmacology JID - 1254354 RN - 0 (Analgesics, Opioid) RN - 0 (Antidepressive Agents, Tricyclic) RN - 0 (GABA Agonists) RN - 0 (GABA Antagonists) RN - 0 (Organophosphorus Compounds) RN - 0 (Receptors, GABA-B) RN - 76I7G6D29C (Morphine) RN - 87TI61875H (CGP 35348) RN - H789N3FKE8 (Baclofen) RN - OGG85SX4E4 (Imipramine) SB - IM MH - Analgesics, Opioid/pharmacology MH - Animals MH - Antidepressive Agents, Tricyclic/*pharmacology MH - Baclofen/pharmacology MH - GABA Agonists/*pharmacology MH - GABA Antagonists/*pharmacology MH - Imipramine/*pharmacology MH - Ligation MH - Male MH - Mice MH - Morphine/pharmacology MH - Organophosphorus Compounds/pharmacology MH - Pain Measurement/*drug effects MH - Receptors, GABA-B/*drug effects/physiology MH - Sciatic Nerve/injuries EDAT- 2000/10/26 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/10/26 11:00 PHST- 2000/10/26 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/10/26 11:00 [entrez] AID - S0014299900006488 [pii] AID - 10.1016/s0014-2999(00)00648-8 [doi] PST - ppublish SO - Eur J Pharmacol. 2000 Oct 27;407(1-2):65-72. doi: 10.1016/s0014-2999(00)00648-8.